Position in SLDB
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$120,240,898
+$52,993,057 QoQ
Shares Held
12,036,126
+28.9% QoQ
Ownership
11.2%
of shares outstanding
% of Portfolio
1.06%
of 13F equity value
Holder Rank
#1
of 155 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SLDB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026RA CAPITAL MANAGEMENT, L.P. holds $11,082,969,028 across 75 Biotechnology names. SLDB ranks #23 (1.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ASND |
Ascendis Pharma A/S
|
10,281,496 | $2,742,280,613 | |
| 2 | PBLS |
Parabilis Medicines, Inc.
|
28,933,371 | $791,906,364 | |
| 3 | RYTM |
Rhythm Pharmaceuticals, Inc.
|
6,666,837 | $740,218,912 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
11,474,599 | $667,018,439 | |
| 5 | SION |
Sionna Therapeutics, Inc.
|
9,905,045 | $435,722,929 | |
| 6 | TYRA |
Tyra Biosciences, Inc.
|
12,198,625 | $389,624,082 | |
| 7 | EWTX |
Edgewise Therapeutics, Inc.
|
8,392,730 | $340,996,619 | |
| 8 | NAMS |
NewAmsterdam Pharma Co N.V.
|
9,883,524 | $330,779,298 |
All Filings in SLDB
Export CSV
30 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $120,240,898 | 12,036,126 | Shares | Sole | 2026-08-14 | |
| 2026-06-22 | $99,899,845 | 12,036,126 | Shares | Sole | 2026-06-24 | |
| 2026-03-31 | $67,247,841 | 9,339,978 | Shares | Sole | 2026-05-15 | |
| 2026-03-13 | $68,083,556 | 9,313,756 | Shares | Sole | 2026-03-17 | |
| 2026-03-06 | $65,231,500 | 9,663,926 | Shares | Sole | 2026-03-10 | |
| 2025-12-31 | $32,776,425 | 5,811,423 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $35,856,479 | 5,811,423 | Shares | Sole | 2025-11-14 | |
| 2025-08-12 | $48,304,960 | 7,997,510 | Shares | Sole | 2025-08-14 | |
| 2025-06-30 | $28,301,143 | 5,811,323 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $16,022,650 | 4,330,446 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $17,321,784 | 4,330,446 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $30,183,208 | 4,330,446 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $24,553,628 | 4,330,446 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $57,681,540 | 4,330,446 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $21,037,396 | 3,426,286 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $8,634,240 | 3,426,286 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $17,953,738 | 3,426,286 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $16,240,595 | 3,426,286 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $18,433,418 | 3,426,286 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,775,796 | 12,367,873 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,618,609 | 12,367,873 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $14,841,447 | 12,367,873 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $21,643,777 | 12,367,873 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $29,559,216 | 12,367,873 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $45,266,415 | 12,367,873 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $68,394,337 | 12,367,873 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $75,622,393 | 9,976,569 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $9,279,462 | 4,571,164 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $13,393,510 | 4,571,164 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $10,925,081 | 4,571,164 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||